基本信息
浏览量:1
职业迁徙
个人简介
Dr Arpeeta Sharma is a Group Leader in the Cardiovascular Inflammation and Redox Biology laboratory at the Baker Heart and Diabetes Institute. She holds a BSc Hons (King’s College, London) and a Masters and PhD in Pharmacology from University of British Columbia, Vancouver, Canada (2014).
Dr Sharma has a proven track record in cardiovascular biology, in particular diabetes associated cardiovascular complications, endothelial dysfunction and atherosclerosis. She has published 26 papers in the field of vascular biology, including first author publications in high impact factor journals such as the Journal of Clinical Investigation, Diabetes and Atherosclerosis, Thrombosis and Vascular Biology.
In her PhD, Dr Sharma characterised a peptide that could up-regulate the release of protective nitric oxide, the first specific peptide of its kind, which is now undergoing chemical screening in Phase I clinical trials. In 2015, Dr Sharma was awarded the NHMRC Peter Doherty Early Career Fellowship to explore key antioxidant and anti-inflammatory pathways involved in diabetes-induced vascular disease as well as therapeutics to limit cellular damage, without triggering detrimental side effects. In addition,
Dr Sharma is the recipient of several project grants, including a Diabetes Australia Research Program General Grant (2019) and a Bayer Pharmaceuticals grant for New Indications (2019–2020). Dr Sharma has a growing international presence and is the inaugural recipient of the CSANZ-ACvA-ESC Ambassador Fellowship (Cardiovascular Society of Australia and New Zealand, Australian Cardiovascular Alliance, European Society of Cardiology).
Dr Sharma has a proven track record in cardiovascular biology, in particular diabetes associated cardiovascular complications, endothelial dysfunction and atherosclerosis. She has published 26 papers in the field of vascular biology, including first author publications in high impact factor journals such as the Journal of Clinical Investigation, Diabetes and Atherosclerosis, Thrombosis and Vascular Biology.
In her PhD, Dr Sharma characterised a peptide that could up-regulate the release of protective nitric oxide, the first specific peptide of its kind, which is now undergoing chemical screening in Phase I clinical trials. In 2015, Dr Sharma was awarded the NHMRC Peter Doherty Early Career Fellowship to explore key antioxidant and anti-inflammatory pathways involved in diabetes-induced vascular disease as well as therapeutics to limit cellular damage, without triggering detrimental side effects. In addition,
Dr Sharma is the recipient of several project grants, including a Diabetes Australia Research Program General Grant (2019) and a Bayer Pharmaceuticals grant for New Indications (2019–2020). Dr Sharma has a growing international presence and is the inaugural recipient of the CSANZ-ACvA-ESC Ambassador Fellowship (Cardiovascular Society of Australia and New Zealand, Australian Cardiovascular Alliance, European Society of Cardiology).
研究兴趣
论文共 40 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Arpeeta Sharma, Judy Choi, Lachlan Sim, Abhiroop Dey,Muthukumar Mohan,Phillip Kantharidis,Lisa Dietz,Peter Sandner,Judy B. de Haan
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023): 1220095-1220095
Arpeeta Sharma,Judy S. Y. Choi,Anna M. D. Watson, Leila Li, Thomas Sonntag,Man K. S. Lee,Andrew J. Murphy,Miles De Blasio,Geoffrey A. Head,Rebecca H. Ritchie, Judy B. de Haan
Scientific Reportsno. 1 (2023): 1-15
Mitchel Tate,Darnel Prakoso,Andrew M Willis, Cheng Peng,Minh Deo,Cheng Xue Qin, Jesse L Walsh,David M Nash,Charles D Cohen, Alex K Rofe,Arpeeta Sharma,Helen Kiriazis,
Frontiers in physiology (2021): 734320-734320
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn